SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-285579
Filing Date
2020-11-04
Accepted
2020-11-04 16:15:34
Documents
12
Period of Report
2020-10-29
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d88934d8k.htm   iXBRL 8-K 25273
  Complete submission text file 0001193125-20-285579.txt   143929

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20201029.xsd EX-101.SCH 3081
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20201029_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20201029_pre.xml EX-101.PRE 10960
5 EXTRACTED XBRL INSTANCE DOCUMENT d88934d8k_htm.xml XML 3231
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 201286878
SIC: 2834 Pharmaceutical Preparations